Skip to main content
. 2017 Jun 13;15:137. doi: 10.1186/s12967-017-1237-1

Fig. 1.

Fig. 1

Reduction in Anxiety Score on the HADS_T Scale after Xenon Administration. Patients with only PD (group 1, n = 42) and “comorbid” PD (group 2, n = 39) where administered 6–7 sessions of xenon inhalation as described in “Methods”. Analysis of HADS_T score was performed. Error bars indicate 95% CI